Allos Raises $5M to Apply Causal AI Across Complex Drug Reformulation

Allos AI today announced $5 million in seed financing led by Oxford Science Enterprises (OSE) to commercialize the industry's ...
KTLA

Ascletis Announces First Participants with Obesity or Overweight Dosed in Its U.S. 12-week Phase IIa Study Evaluating Once-Monthly Subcutaneous Depot Formulation of Small ...

- First participants with obesity or overweight with at least one weight-related comorbidity have been dosed in a U.S. 12-week Phase IIa study with once-monthly subcutaneous (SQ) depot formulation of ...
Nasdaq

InMed Pharmaceuticals Demonstrates INM-901 as an Oral Formulation Targeting Alzheimer's Disease

Vancouver, British Columbia--(Newsfile Corp. - August 20, 2024) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of ...
Contract Pharma

Targeted Modalities Set Elevated Standards for Precision

The advent and proliferation of targeted modalities represent an evolutionary leap forward in drug development. By binding ...
News-Medical.Net

Building scalable formulations through process optimization

Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.
Morningstar

Altasciences Receives 2025 CDMO Leadership Award in Small Molecule Dosage Form Category

Altasciences, a nine-time CRO Leadership Award winner, is proud to announce they have been awarded a 2025 CDMO Leadership Award in the Small Molecule Dosage Form–North America category. This press ...
Case Western Reserve University

Small Molecule Drug Development Core

Small Molecule Drug Development Core Facility (SMDD Core) has the automation equipment, libraries, and experienced personnel to support a wide range of assay ...